Oh Sung Jin, Shin Jin Yong
Department of Surgery, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea.
J Korean Surg Soc. 2012 Mar;82(3):165-71. doi: 10.4174/jkss.2012.82.3.165. Epub 2012 Feb 27.
Currently, circumferential resection margins (CRM) are used as a clinical endpoint in studies on the prognosis of rectal cancer. Although the concept of a circumferential resection margin in extraperitoneal rectal cancer differs from that in intraperitoneal rectal cancer due to differences in anatomical and biologic behaviors, previous reports have provided information on CRM involvement in all types of rectal cancer including intraperitoneal lesions. Therefore, the aim of this study was to analyze risk factors of CRM involvement in extraperitoneal rectal cancer.
From January 2005 to December 2008, 306 patients with extraperitoneal rectal cancer were enrolled in a prospectively collected database. Multivariate logistic regression analysis was used to identify predictors of CRM involvement.
The overall rate of CRM involvement was found to be 16.0%. Multivariate analysis showed that male sex, larger tumor size (≥4 cm), stage higher than T3, nodal metastasis, tumor perforation and non-sphincter preserving proctectomy (NSPP) were risk factors for CRM involvement.
Male sex, larger tumor size (≥4 cm), advanced T stage, nodal metastasis, tumor perforation, and NSPP are significant risk factors of CRM involvement in extraperitoneal rectal cancer. Given that postoperative chemoradiotherapy is recommended for patients with a positive CRM, further oncologic studies are warranted to ascertain which patients with these risk factors would require adjuvant therapy.
目前,环周切缘(CRM)在直肠癌预后研究中用作临床终点。尽管由于解剖学和生物学行为的差异,腹膜外直肠癌的环周切缘概念与腹膜内直肠癌不同,但既往报告提供了包括腹膜内病变在内的所有类型直肠癌CRM受累情况的信息。因此,本研究旨在分析腹膜外直肠癌CRM受累的危险因素。
2005年1月至2008年12月,306例腹膜外直肠癌患者被纳入前瞻性收集的数据库。采用多因素逻辑回归分析确定CRM受累的预测因素。
发现CRM受累的总体发生率为16.0%。多因素分析显示,男性、肿瘤较大(≥4 cm)、分期高于T3、淋巴结转移、肿瘤穿孔和不保肛直肠切除术(NSPP)是CRM受累的危险因素。
男性、肿瘤较大(≥4 cm)、T分期较晚、淋巴结转移、肿瘤穿孔和NSPP是腹膜外直肠癌CRM受累的重要危险因素。鉴于CRM阳性患者建议术后进行放化疗,有必要进行进一步的肿瘤学研究,以确定哪些具有这些危险因素的患者需要辅助治疗。